S&P Futures
5,907.00 -13.00 (-0.22%) Dow Futures
43,335.00 -205.00 (-0.47%) Nasdaq Futures
20,619.75 -13.75 (-0.07%) Russell 2000 Futures
2,304.00 -13.70 (-0.59%) Crude Oil
68.71 -0.45 (-0.65%) Gold
2,634.20 +19.60 (+0.75%)
Beyond Air, Inc. (XAIR)
Pre-Market:
| Previous Close | 0.5015 |
| Open | 0.5050 |
| Bid | 0.4764 x 200 |
| Ask | 0.5338 x 200 |
| Day's Range | 0.4902 - 0.5385 |
| 52 Week Range | 0.2960 - 2.3600 |
| Volume | |
| Avg. Volume | 581,195 |
| Market Cap | 36.729M |
| Beta (5Y Monthly) | -0.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.4100 |
| Earnings Date | Feb 10, 2025 - Feb 14, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.50 |
GlobeNewswireBeyond Air to Participate in the Piper Sandler 36th Annual Healthcare Conference
GARDEN CITY, N.Y., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of Nitric Oxide (NO) to improve the lives of patients, today announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will participate in one-on-one meetings and a fireside chat at the Piper Sandler 36th Annual Healthcare Conference being held December 3-5, 2024 i
- GlobeNewswire
Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update
Revenues increased 17% compared to the previous quarter ended June 30, 2024 Strengthened balance sheet is expected to provide sufficient cash runway through June 2026 Completed a $20.6 million private placement offering with multiple healthcare-focused institutional funds and Company insiders Retired $17.5 million in debt from Avenue Capital and entered into a $11.5 million loan agreement with an insider-led investor group Conference call scheduled for 4:30 p.m. ET today, November 11th GARDEN CI
